Lista de obras -

A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors ⬇️

artículo científico publicado el 22 de julio de 2013

A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors

artículo científico publicado en 2013

A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study

artículo científico publicado en 2010

Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group

artículo científico publicado en 2009

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study

artículo científico publicado en 2005

An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour

artículo científico

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report

artículo científico publicado en 2019

Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study

artículo científico publicado en 2018

Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.

artículo científico publicado en 2017

Children's Oncology Group's 2013 blueprint for research: rare tumors

artículo científico

Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).

artículo científico publicado en 2014

Decreased Early Mortality in Young Adult Patients With Acute Lymphoblastic Leukemia Treated at Specialized Cancer Centers in California

artículo científico publicado en 2019

Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry

artículo científico publicado en 2016

Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor

artículo científico publicado en 2009

Hepatoblastoma clinical research: lessons learned and future challenges

artículo científico publicado en 2012

Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group

artículo científico publicado en 2018

Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5.

artículo científico publicado en 2010

Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group

artículo científico publicado en 2005

Management of Wilms' tumour: current practice and future goals

artículo científico publicado en 2004

Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials

artículo científico publicado en 2017

Post-transplant multiple myeloma in a pediatric renal transplant patient

artículo científico publicado en 2006

Potential Roles of Total-Body PET/Computed Tomography in Pediatric Imaging

scientific article published on 01 July 2020

Predictors of outcome in children with Langerhans cell histiocytosis

artículo científico publicado en 2005

The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model

artículo científico publicado en 2016

The Depiction of Brown Adipose Tissue Is Related to Disease Status in Pediatric Patients With Lymphoma

artículo científico publicado el 1 de abril de 2012

The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement

artículo científico publicado en 2007

The teen impact experience: a webcast pilot project for teens with cancer and blood diseases.

artículo científico publicado en 2014

Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium

artículo científico publicado en 2014

Treatment Complications and Survival Among Children and Young Adults With Acute Lymphoblastic Leukemia

scientific article published on 11 June 2020

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.

artículo científico publicado en 2018

Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group

artículo científico publicado en 2007

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

artículo científico publicado en 2008

Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study

artículo científico publicado en 2006

Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study.

artículo científico publicado en 2018

Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil

artículo científico publicado en 2006

α-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium

scientific article published on 29 July 2019

Lista de obras de

A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors ⬇️

A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors

A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study

Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study

An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report

Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study

Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.

Children's Oncology Group's 2013 blueprint for research: rare tumors

Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).

Decreased Early Mortality in Young Adult Patients With Acute Lymphoblastic Leukemia Treated at Specialized Cancer Centers in California

Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry

Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor

Hepatoblastoma clinical research: lessons learned and future challenges

Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group

Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5.

Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group

Management of Wilms' tumour: current practice and future goals

Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials

Post-transplant multiple myeloma in a pediatric renal transplant patient

Potential Roles of Total-Body PET/Computed Tomography in Pediatric Imaging

Predictors of outcome in children with Langerhans cell histiocytosis

The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model

The Depiction of Brown Adipose Tissue Is Related to Disease Status in Pediatric Patients With Lymphoma

The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement

The teen impact experience: a webcast pilot project for teens with cancer and blood diseases.

Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium

Treatment Complications and Survival Among Children and Young Adults With Acute Lymphoblastic Leukemia

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.

Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study

Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study.

Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil

α-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium